Angion Announces Partial Waiver of Certain Lock-up Restrictions
UNIONDALE, N.Y., March 19, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp. (NASDAQ:ANGN), a late-stage biopharmaceutical…
UNIONDALE, N.Y., March 19, 2021 (GLOBE NEWSWIRE) — Angion Biomedica Corp. (NASDAQ:ANGN), a late-stage biopharmaceutical…
SparingVision Announces Upcoming Presentations at the Association for Research in Vision and Ophthalmology (ARVO) 2021…
WINNIPEG, Manitoba, March 18, 2021 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the…
SAN DIEGO, March 18, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) — Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage…
DALLAS, March 18, 2021 (GLOBE NEWSWIRE) — Instil Bio, Inc. (“Instil”), a clinical-stage biopharmaceutical company…
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. Topline data from Phase…
– ARCALYST is the first and only FDA-approved therapy for recurrent pericarditis –– Commercial launch…
AUSTIN, Texas, March 18, 2021 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…
Conference Call and Webcast to be Held at 4:30 p.m. ET NEW HAVEN, Conn., March…
BURLINGAME, Calif., March 18, 2021 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq:…
– Objective Response Rate Endpoint Not Met – EXTON, Pa., March 18, 2021 (GLOBE NEWSWIRE)…
Conference Call and Live Audio Webcast Scheduled for Today, Thursday, March 18, 2021, 4:30 p.m….
Reports approximately 82,000 tests in the fourth quarter of 2020 Raised $118M gross proceeds in…
CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company…
MELVILLE, N.Y., March 18, 2021 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”)…
HIGH POINT, N.C., March 18, 2021 (GLOBE NEWSWIRE) — vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage…
Wide-ranging transformation program completed R&D Day scheduled for April 28, 2021, to provide data updates,…
REDWOOD CITY, Calif., March 18, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a…
-AGTC will highlight the value of the patient voice in gene therapy development- GAINESVILLE, Fla….